Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New management strategies in ARDS. Immunomodulation.

Jean-Louis Vincent1

  • 1Department of Intensive Care, Erasme Hospital, Free University of Brussels, Brussels, Belgium. jlvincen@ulb.ac.be

Critical Care Clinics
|March 26, 2002
PubMed
Summary

Acute respiratory distress syndrome (ARDS) management is evolving. Immunomodulatory strategies, alongside improved support, are showing promise in reducing ARDS mortality and improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A liberal strategy of red blood cell transfusion reduces cardiogenic shock in elderly patients undergoing cardiac surgery.

The Journal of thoracic and cardiovascular surgery·2015
Same author

A new device for the prevention of pulmonary embolism in critically ill patients: Results of the European Angel Catheter Registry.

The journal of trauma and acute care surgery·2015
Same author

A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2015
Same author

Near infrared spectroscopy (NIRS) to assess the effects of local ischemic preconditioning in the muscle of healthy volunteers and critically ill patients.

Microvascular research·2015
Same author

Should red cell transfusion be individualized? Yes.

Intensive care medicine·2015
Same author

Assessing Cellular Responses in Sepsis.

EBioMedicine·2015

Area of Science:

  • Critical Care Medicine
  • Immunology
  • Pulmonology

Background:

  • Acute Respiratory Distress Syndrome (ARDS) is a critical illness with high morbidity and mortality.
  • Understanding ARDS pathogenesis involves inflammatory pathways, prompting research into immune-modifying treatments.

Purpose of the Study:

  • To explore immunomodulatory strategies for improving outcomes in critically ill patients with ARDS.
  • To highlight the systemic nature of ARDS and the need for comprehensive treatment approaches.

Main Methods:

  • Review of current understanding of ARDS inflammatory processes.
  • Evaluation of existing and emerging immunomodulatory agents, including activated protein C.
  • Discussion of supportive care measures like nutrition and ventilation.

Main Results:

  • Immunomodulatory agents are demonstrating positive results in clinical trials.
  • Activated protein C is one example of a successful immunomodulatory therapy.
  • Combined therapeutic approaches, potentially involving multiple agents, are likely necessary for optimal ARDS management.

Conclusions:

  • ARDS treatment requires a systemic, not just lung-limited, approach.
  • Immunomodulatory therapies are becoming integral to ARDS management, contributing to falling mortality rates.
  • Future ARDS care will likely involve personalized, multi-agent treatment strategies.

Related Experiment Videos